GDTC
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ: GDTC · HEALTHCARE · BIOTECHNOLOGY
$1.00
+0.71% today
Updated 2026-04-30
Market cap
$11.60M
P/E ratio
—
P/S ratio
13.47x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
CytoMed Therapeutics Limited Ordinary Shares (GDTC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $2.17M | $2.89M | $4.51M | $3.90M | $9.37M | $7.37M |
| Cash & equivalents | $275826.00 | $670269.00 | $1.86M | $1.18M | $6.82M | $3.64M |
| Current assets | $404440.00 | $1.11M | $2.43M | $1.86M | $7.65M | $4.39M |
| Total liabilities | $742310.00 | $2.53M | $2.59M | $3.46M | $852276.00 | $749763.00 |
| Current liabilities | $277464.00 | $2.06M | $2.18M | $3.11M | $543278.00 | $444180.00 |
| Long-term debt | — | $590674.00 | $539119.00 | $468827.00 | $407772.00 | $394310.00 |
| Shareholder equity | $1.43M | $360370.00 | $1.92M | $438241.00 | $8.52M | $6.57M |
| Retained earnings | $-803249.00 | $-2.28M | $-3.76M | $-6.12M | $-9.34M | $-10.87M |
| Accounts receivable | $0.00 | $229571.00 | $15222.00 | $54536.00 | $204748.00 | $13752.00 |
| Inventory | $35446.00 | $182046.00 | $320005.00 | $430172.00 | $514320.00 | $614204.00 |
| Goodwill | $263.00 | $268.00 | $263.00 | $265.00 | $269.00 | $259.00 |